228
Views
9
CrossRef citations to date
0
Altmetric
Review

Pneumococcal vaccination in celiac disease

, , , , , , , & show all
Pages 541-546 | Received 16 Jan 2019, Accepted 10 Apr 2019, Published online: 23 Apr 2019

References

  • Lebwohl B, Sanders DS, Green PHR. Celiac disease. Lancet. 2018;391:70–81.
  • Kneepkens CM, von Blomberg BM. Clinical practice: celiac disease. Eur J Pediatr. 2012;171:1011–1021.
  • Saalman R, Fällström SP. High incidence of urinary tract infection in patients with celiac disease. Arch Dis Child. 1996;74:170–171.
  • Ludvigsson JF, Sanders DS, Maeurer M, et al. Risk of tuberculosis in a large sample of patients with celiac disease -a nationwide cohort study. Aliment Pharmacol Ther. 2011;33:689–696.
  • Thomas HJ, Wotton CJ, Yeates D, et al. Pneumococcal infection in patients with celiac disease. Eur J Gastroenterol Hepatol. 2008;20:624–628.
  • Röckert Tjernberg A, Bonnedahl J, Inghammar M, et al. Celiac disease and invasive pneumococcal disease: a population-based cohort study. Epidemiol Infect. 2017;145:1203–1209.
  • Ludvigsson JF, Olén O, Bell M, et al. Celiac disease and risk of sepsis. Gut. 2008;57:1074–1080.
  • Bullen AW, Hall R, Gowland G, et al. Hyposplenism, adult celiac disease, and autoimmunity. Gut. 1981;22:28–33.
  • Harms Pritchard G, Pepper M. Memory B cell heterogeneity: remembrance of things past. J Leukoc Biol. 2018;103:269–274.
  • Simons M, Scott-Sheldon LAJ, Risech-Neyman Y, et al. Celiac disease and increased risk of pneumococcal infection: a systematic review and meta-analysis. Am J Med. 2018;131:83–89.
  • Di Sabatino A, Brunetti L, Carnevale MG, et al. Is it worth investigating splenic function in patients with celiac disease? World J Gastroenterol. 2013;19:2313–2318.
  • Di Sabatino A, Rosado MM, Ciccocioppo R, et al. Depletion of immunoglobulin M memory B cells is associated with splenic hypofunction in inflammatory bowel disease. Am J Gastroenterol. 2005;100:1788–1795.
  • Di Sabatino A, Carnevale Maffè G, Brunetti L, et al. Splenic hypofunction in patients with an incidental finding of small-sized spleen at abdominal ultrasound. Intern Emerg Med. 2013;8:361–362.
  • Corazza GR, Zoli G, Di Sabatino A, et al. A reassessment of splenic hypofunction in celiac disease. Am J Gastroenterol. 1999;94:391–397.
  • Di Sabatino A, Rosado MM, Cazzola P, et al. Splenic hypofunction and the spectrum of autoimmune and malignant complications in celiac disease. Clin Gastroenterol Hepatol. 2006;4:179–186.
  • Bjarnason I, Marsh MN, Price A, et al. Intestinal permeability in patients with celiac disease and dermatitis herpetiformis. Gut. 1985;26:1214–1219.
  • Wierdsma NJ, van Bokhorst-de van der Schueren MA, Berkenpas M, et al. Vitamin and mineral deficiencies are highly prevalent in newly diagnosed celiac disease patients. Nutrients. 2013;5:3975–3992.
  • Doig CJ, Sutherland LR, Sandham JD, et al. Increased intestinal permeability is associated with the development of multiple organ dysfunction syndrome in critically ill ICU patients. Am J Respir Crit Care Med. 1998;158:444–451.
  • Robertson DA, Taylor N, Sidhu H, et al. Pulmonary permeability in celiac disease and inflammatory bowel disease. Digestion. 1989;42:98–103.
  • Ludvigsson JF, Bai JC, Biagi F, et al. BSG celiac disease guidelines development group; British society of gastroenterology. Diagnosis and management of adult celiac disease: guidelines from the British society of gastroenterology. Gut. 2014;63:1210–1228.
  • William BM, Corazza GR. Hyposplenism: a comprehensive review. Part I: basic concepts and causes. Hematology. 2007;12:1–13.
  • Rubio-Tapia A, Hill ID, Kelly CP, et al. American college of gastroenterology. ACG clinical guidelines: diagnosis and management of celiac disease. Am J Gastroenterol. 2013;108:656–676.
  • O‘Donoghue DJ. Fatal pneumococcal septicaemia in celiac disease. Postgrad Med J. 1986;62:229–230.
  • Parnell N, Thomas P. Fatal pneumococcal septicaemia in a celiac patient. Eur J Gastroenterol Hepatol. 1998;10:899–900.
  • Ouseph MM, Simons M, Treaba DO, et al. Fatal streptococcus pneumoniae sepsis in a patient with celiac disease-associated hyposplenism. ACG Case Rep J. 2016;3:e140.
  • Walters JR, Bamford KB, Ghosh S. Celiac disease and the risk of infections. Gut. 2008;57:1034–1035.
  • Peters U, Askling J, Dridley G, et al. Causes of death in patients with Celiac disease in a population-based Swedish cohort. Arch Intern Med. 2003;163:1566–1572.
  • Grainge MJ, West J, Card TR, et al. Causes of death in people with celiac disease spanning the pre- and post-serology era: a population-based cohort study from Derby, UK. Am J Gastroenterol. 2011;106:933–939.
  • Abdul Sultan A, Crooks CJ, Card T, et al. Causes of death in people with celiac disease in England compared with the general population: a competing risk analysis. Gut. 2015;64:1220–1226.
  • Zingone F, Abdul Sultan A, Crooks CJ, et al. The risk of community-acquired pneumonia among 9803 patients with celiac disease compared to the general population: a cohort study. Aliment Pharmacol Ther. 2016;44:57–67.
  • Emilsson L, Lebwohl B, Green PH, et al. Mucosal healing and the risk of serious infections in patients with celiac disease. United European Gastroenterol J. 2018;6:55–62.
  • Khan J, Jennings A, Subramanian S. OC-021 A retrospective audit of pneumococcal & influenza vaccination in celiac disease. Gut. 2013;62:A9–A10.
  • Di Sabatino A, Lenti MV, Tinozzi FP, et al. Vaccination coverage and mortality after splenectomy: results from an Italian single-centre study. Intern Emerg Med. 2017;12:1139–1147.
  • Durando P, Alicino C, De Florentiis D, et al. Improving the protection against Streptococcus pneumoniae with the new generation 13-valent pneumococcal conjugate vaccine. J Prev Med Hyg. 2012;53:68–77.
  • World Health Organization. Pneumococcal vaccines WHO position paper–2012. Wkly Epidemiol Rec. 2012;87:129–144.
  • American Academy of Pediatrics Committee on Infectious Diseases. Recommendations for the prevention of Streptococcus pneumoniae infections in infants and children: use of 13-valent pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide vaccine (PPSV23). Pediatrics. 2010;126:186–190.
  • Bonanni P, Chiamenti G, Conforti G, et al. Scientific board of “lifetime immunization schedule”. The 2016 lifetime immunization schedule, approved by the Italian scientific societies: A new paradigm to promote vaccination at all ages. Hum Vaccin Immunother. 2017;13:2531–2537.
  • Backhaus E, Berg S, Andersson R, et al. Epidemiology of invasive pneumococcal infections: manifestations, incidence and case fatality rate correlated to age, gender and risk factors. BMC Infect Dis. 2016;16:367.
  • Anania C, Olivero F, Spagnolo A, et al. Immune response to vaccines in children with celiac disease. World J Gastroenterol. 2017;23:3205–3213.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.